Patients Acceptance Towards Elective Labor in Induction (PALI)
PALI
1 other identifier
observational
200
1 country
1
Brief Summary
To assess patients' preference, understanding regarding elective IOL and factors contribute to decision making process towards elective IOL at 39th week of gestation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2021
CompletedFirst Posted
Study publicly available on registry
February 3, 2021
CompletedStudy Start
First participant enrolled
March 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedAugust 5, 2022
August 1, 2022
1 year
January 22, 2021
August 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients accept to undergo elective induction of labor at 39th gestational week
Number of patients who are willing to undergo elective Induction of labor without maternal of fetal indication at 39th gestational week
It is planned to fill the questionnaire in 30 minutes at 39th gestational week
Secondary Outcomes (5)
Participants knowledge
It is planned to fill the questionnaire in 30 minutes at 36th gestational week
Participants opinions
It is planned to fill the questionnaire in 30 minutes at 36th gestational week
Reasons to choose or refuse elective induction of labor at 36th gestational week
It is planned to fill the questionnaire in 30 minutes at 36th gestational week
Reason why participants change initial decision about elective induction of labor
It is planned to fill the questionnaire in 30 minutes at 39th gestational week
Factors that may affect participants' decision
It is planned to fill the questionnaire in 30 minutes at 36th gestational week
Interventions
Survey comprised of a series of multiple choice questions
Eligibility Criteria
Low risk pregnant women with a gestational age at 36th week and 39th weeks
You may qualify if:
- Maternal age ≥ 18
- Singleton pregnancy (twin gestation reduced to singleton, either spontaneously or therapeutically, is not eligible unless the reduction occurred before 14 weeks project gestational age)
- Gestational age at 36+0 weeks to 36+6 week
- Cephalic presentation
- No contraindications to vaginal delivery
You may not qualify if:
- Previous C-section
- Maternal medical illness associated with increased risk of adverse pregnancy outcome (any diabetes mellitus, any hypertensive disorders, cardiac diseases, renal insufficiency, systemic lupus erythematosus, mental disorders, HIV positive, use of heparin or low-molecular weight heparin during the current pregnancy etc.)
- Abnormal placenta: Active vaginal bleeding greater than bloody show or placenta previa, accreta or vasa previa
- Abnormal amniotic fluid volume:
- Oligohydramnios (MVP \< 2cm) Polyhydramnios (MVP \> 10cm)
- Abnormal fetus Fetal demise or known major fetal anomalies Fetal growth restriction (FGR) (EFW \< 3% or \< 10% and abnormal Doppler) Non-reassuring fetal status (no fetal movements, abnormal fetal heart rate at auscultation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hanoi Obstetrics and Gynecology Hospitallead
- Mỹ Đức Hospitalcollaborator
Study Sites (1)
Hanoi Obstetrics and Gynecology Hospital
Hanoi, Hanoi, 10000, Vietnam
Related Publications (5)
ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol. 2009 Aug;114(2 Pt 1):386-397. doi: 10.1097/AOG.0b013e3181b48ef5. No abstract available.
PMID: 19623003RESULTChen HY, Grobman WA, Blackwell SC, Chauhan SP. Neonatal and Maternal Adverse Outcomes Among Low-Risk Parous Women at 39-41 Weeks of Gestation. Obstet Gynecol. 2019 Aug;134(2):288-294. doi: 10.1097/AOG.0000000000003372.
PMID: 31306312RESULTGrobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, Hill K, Thom EA, El-Sayed YY, Perez-Delboy A, Rouse DJ, Saade GR, Boggess KA, Chauhan SP, Iams JD, Chien EK, Casey BM, Gibbs RS, Srinivas SK, Swamy GK, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. N Engl J Med. 2018 Aug 9;379(6):513-523. doi: 10.1056/NEJMoa1800566.
PMID: 30089070RESULTGallagher PJ, Liveright E, Mercier RJ. Patients' perspectives regarding induction of labor in the absence of maternal and fetal indications: are our patients ready for the ARRIVE trial? Am J Obstet Gynecol MFM. 2020 May;2(2):100086. doi: 10.1016/j.ajogmf.2020.100086. Epub 2020 Jan 12.
PMID: 33345957RESULTMiddleton P, Shepherd E, Morris J, Crowther CA, Gomersall JC. Induction of labour at or beyond 37 weeks' gestation. Cochrane Database Syst Rev. 2020 Jul 15;7(7):CD004945. doi: 10.1002/14651858.CD004945.pub5.
PMID: 32666584RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Anh Nguyen Duy, PhD. MD
Hanoi Obstetric and Gynecology Hospital
- PRINCIPAL INVESTIGATOR
Ha Nguyen Thi Thu, PhD. MD
Hanoi Obstetric and Gynecology Hospital
- PRINCIPAL INVESTIGATOR
Minh Chau Ngoc, MD
Mỹ Đức Hospital
- STUDY CHAIR
Ben W Mol, PhD. MD
Monash University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2021
First Posted
February 3, 2021
Study Start
March 15, 2021
Primary Completion
March 15, 2022
Study Completion
June 30, 2022
Last Updated
August 5, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share